市场调查报告书

抗真菌药物的全球市场分析:各药物类别、适应症、地区的未来预测

Global Antifungal Drug Market Size study, by Drug Class (Azoallyamines, Echinocandins, Polyenes, Allyamines, Others), by Indication (Dermatophytosis, Aspergillosis, Candidiasis, Others) and Regional Forecasts 2018-2025

出版商 Bizwit Research & Consulting LLP 商品编码 744566
出版日期 内容资讯 英文
商品交期: 2-3个工作天内
价格
Back to Top
抗真菌药物的全球市场分析:各药物类别、适应症、地区的未来预测 Global Antifungal Drug Market Size study, by Drug Class (Azoallyamines, Echinocandins, Polyenes, Allyamines, Others), by Indication (Dermatophytosis, Aspergillosis, Candidiasis, Others) and Regional Forecasts 2018-2025
出版日期: 2018年10月16日内容资讯: 英文
简介

本报告提供全球抗真菌药物的市场相关分析,市场基本结构 (价值链等) 和主要的促进、阻碍因素,整体市场规模趋势预测 (过去3年、今后8年份),各类药物、各适应症及各地区详细趋势,主要企业的简介、市场占有率等资讯汇整,为您概述为以下内容。

第1章 摘要整理

第2章 全球抗真菌药物市场:定义和范围

第3章 全球抗真菌药物市场动态

  • Seesaw分析
    • 推动市场要素
    • 阻碍市场要素
    • 市场机会

第4章 全球抗真菌药物市场:产业分析

  • 波特的五力分析
  • PEST分析
    • 政治、经济、社会、技术性方案
  • 价值链分析
    • 供应商
    • 厂商/服务供应商
    • 经销商
    • 终端用户
  • 主要的购买标准
  • 管理体制
  • 成本结构分析
    • 原料费
    • 制造费
    • 人事费用
  • 投资/引进方案
  • 分析师的建议,结论

第5章 全球抗真菌药物市场动态:各类药物

  • 市场现状
  • 市场实际成果:潜在的模式
  • 各市场区隔分析
    • Azoallyamines
    • Echinocandins
    • Polyenes
    • 丙烯基胺
    • 其他

第6章 全球抗真菌药物市场:各适应症

  • 市场现状
  • 市场实际成果:潜在的模式
  • 各市场区隔分析
    • 皮肤丝状菌症 (癣)
    • 曲菌症
    • 念珠菌感染
    • 其他

第7章 全球抗真菌药物市场:各地区分析

  • 抗真菌药物市场:各地区的概况 (总计11年份)
  • 北美市场 (美国,加拿大)
  • 欧洲市场 (英国,德国,法国等)
  • 亚洲市场 (中国,印度,日本等)
  • 南美市场 (巴西,墨西哥)
  • 其他的国家的市场 (RoW:南美,中东、非洲)

第8章 企业资料

  • 各企业市场占有率
  • 大企业的策略
  • 企业简介
    • Novartis
    • Pfizer Inc
    • Bayer Healthcare
    • Sanofi Aventis
    • Merck and Co Inc
    • Glaxosmith Kline
    • Abbott Laboratories
    • Glenmark Pharmaceuticals Ltd
    • Enzon Pharmaceuticals
    • Astellas Pharma Inc

第9章 分析过程

目录

Global Antifungal Drug Market valued approximately USD 14.27 billion in 2017 is anticipated to grow with a healthy growth rate of more than 3.85% over the forecast period 2018-2025.

Global Antifungal Drug Market to reach USD 19.30 billion by 2025.The rising incident of many Fungal infections. These infections may lead to death in patients with a compromised immune system, such as in individuals who acquired immune deficiency syndrome and leukemia, and is termed as opportunistic infections. The increasing prevalence of infectious diseases and hospital-acquired infections is expected to fuel the demand for therapeutics over the forecast period. Fungal infection is found to attack both superficial and systemic parts of the body, in the skin, eye, mouth, and vagina, leading to diseases, such as athlete's foot, fungal meningitis, and ringworm, which are treated using antifungal products. A wide range of fungicidal preparations, such as creams, sprays, tablets, and injections, are available and increasing adoption of these products is predicted to drive the demand over the next seven years.

The regional analysis of Global Antifungal Drug Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America, on account of high patient awareness levels and R&D intensity pertaining to new drug development, led the market in 2017 Other regions, such as Asia Pacific and Latin America, growing at a faster growth rate. Asia Pacific is anticipated to witness the fastest CAGR during the forecast period. The presence of huge target population, growing establishment of healthcare facilities, and high unmet clinical needs related to fungal diseases are anticipated to provide a potential growth platform to this region for pharmaceutical players.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

  • Azoallyamines,
  • Echinocandins
  • Polyenes,
  • Allyamines,
  • Others

By Indication:

  • Dermatophytosis
  • Aspergillosis
  • Candidiasis
  • Others

By Regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2015, 2016
  • Base year - 2017
  • Forecast period - 2018 to 2025

The industry is seeming to be fairly competitive. Some of the leading market players include Novartis, Pfizer Inc, Bayer Healthcare, Sanofi Aventis, Merck and Co Inc, Glaxosmith Kline , Abbott Laboratories, Glenmark Pharmaceuticals Ltd, Enzon Pharmaceuticals, Astellas Pharma Inc and so on. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global Antifungal Drug Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

TABLE OF CONTENTS

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
    • 1.3.1. Global Antifungal Drug Market, by Region, 2015-2025 (USD Billion)
    • 1.3.2. Global Antifungal Drug Market, by Substrate, 2015-2025 (USD Billion)
    • 1.3.3. Global Antifungal Drug Market, by Regeneration Catalyst, 2015-2025 (USD Billion)
    • 1.3.4. Global Antifungal Drug Market, by On-Highway Vehicle, 2015-2025 (USD Billion)
  • 1.4. Estimation Methodology

Chapter 2. Global Antifungal Drug Market Definition and Scope

  • 2.1. Research Objective
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates
  • 2.5. Report Limitation

Chapter 3. Global Antifungal Drug Market Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Antifungal Drug Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Value Chain Analysis
    • 4.3.1. Supplier
    • 4.3.2. Manufacturers/Service Provider
    • 4.3.3. Distributors
    • 4.3.4. End-Users
  • 4.4. Key Buying Criteria
  • 4.5. Regulatory Framework
  • 4.6. Cost Structure Analysis
    • 4.6.1. Raw Material Cost Analysis
    • 4.6.2. Manufacturing Cost Analysis
    • 4.6.3. Labour Cost Analysis
  • 4.7. Investment Vs Adoption Scenario
  • 4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Antifungal Drug Market, By Drug Class

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Global Antifungal Drug Market, Sub Segment Analysis
    • 5.3.1. Azoallyamines
      • 5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.3.2. Echinocandins
      • 5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.3.3. Polyenes
      • 5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.3.4. Allyamines
      • 5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.3.5. Others
      • 5.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. Global Antifungal Drug Market, By Indication

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Global Antifungal Drug Market, Sub Segment Analysis
    • 6.3.1. Dermatophytosis
      • 6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.3.2. Aspergillosis
      • 6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.3.3. Candidiasis
      • 6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.3.4. Others
      • 6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7. Global Antifungal Drug Market, by Regional Analysis

  • 7.1. Antifungal Drug Market, Regional Market Snapshot (2015-2025)
  • 7.2. North America Antifungal Drug Market Snapshot
    • 7.2.1. U.S.
      • 7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.1.2. Drug Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.1.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.2.2. Canada
      • 7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.2.2. Drug Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.2.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.3. Europe Antifungal Drug Market Snapshot
    • 7.3.1. U.K.
      • 7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.1.2. Drug Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.1.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.2. Germany
      • 7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.2.2. Drug Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.2.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.3. France
      • 7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.3.2. Drug Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.3.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.4. Rest of Europe
      • 7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.4.2. Drug Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.4.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.4. Asia Antifungal Drug Market Snapshot
    • 7.4.1. China
      • 7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.1.2. Drug Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.1.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.2. India
      • 7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.2.2. Drug Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.2.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.3. Japan
      • 7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.3.2. Drug Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.3.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.4. Rest of Asia Pacific
      • 7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.4.2. Drug Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.4.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.5. Latin America Antifungal Drug Market Snapshot
    • 7.5.1. Brazil
      • 7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.1.2. Drug Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.1.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.5.2. Mexico
      • 7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.2.2. Drug Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.2.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.6. Rest of The World
    • 7.6.1. South America
      • 7.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.1.2. Drug Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.1.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.6.2. Middle East and Africa
      • 7.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.2.2. Drug Class breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.2.3. Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8. Competitive Intelligence

  • 8.1. Company Market Share (Subject to Data Availability)
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Novartis
      • 8.3.1.1. Overview
      • 8.3.1.2. Financial (Subject to Data Availability)
      • 8.3.1.3. Product Summary
      • 8.3.1.4. Recent Developments
    • 8.3.2. Pfizer Inc
    • 8.3.3. Bayer Healthcare
    • 8.3.4. Sanofi Aventis
    • 8.3.5. Merck and Co Inc
    • 8.3.6. Glaxosmith Kline
    • 8.3.7. Abbott Laboratories
    • 8.3.8. Glenmark Pharmaceuticals Ltd
    • 8.3.9. Enzon Pharmaceuticals
    • 8.3.10. Astellas Pharma Inc

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
    • 9.1.6. Research Assumption

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL ANTIFUNGAL DRUG MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL ANTIFUNGAL DRUG MARKET
  • TABLE 3. GLOBAL ANTIFUNGAL DRUG MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. GLOBAL ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
  • TABLE 7. GLOBAL ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)
  • TABLE 8. GLOBAL ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)
  • TABLE 9. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 10. GLOBAL ANTIFUNGAL DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 11. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 12. GLOBAL ANTIFUNGAL DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 13. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 14. GLOBAL ANTIFUNGAL DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 15. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 16. GLOBAL ANTIFUNGAL DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 17. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 18. GLOBAL ANTIFUNGAL DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 19. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 20. GLOBAL ANTIFUNGAL DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 21. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 22. GLOBAL ANTIFUNGAL DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 23. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 24. GLOBAL ANTIFUNGAL DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 25. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 26. GLOBAL ANTIFUNGAL DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 27. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 28. GLOBAL ANTIFUNGAL DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 29. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 30. GLOBAL ANTIFUNGAL DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 31. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 32. GLOBAL ANTIFUNGAL DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 33. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 34. GLOBAL ANTIFUNGAL DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 35. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 36. GLOBAL ANTIFUNGAL DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 37. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 38. GLOBAL ANTIFUNGAL DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 39. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 40. GLOBAL ANTIFUNGAL DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 41. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 42. GLOBAL ANTIFUNGAL DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 43. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 44. GLOBAL ANTIFUNGAL DRUG MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 45. U.S. ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 46. U.S. ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 47. U.S. ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 48. U.S. ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 49. U.S. ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 50. CANADA ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 51. CANADA ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 52. CANADA ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 53. CANADA ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 54. CANADA ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 55. UK ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 56. UK ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 57. UK ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 58. UK ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 59. UK ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 60. GERMANY ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 61. GERMANY ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 62. GERMANY ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 63. GERMANY ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 64. GERMANY ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 65. ROE ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 66. ROE ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 67. ROE ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 68. ROE ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 69. ROE ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 70. CHINA ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 71. CHINA ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 72. CHINA ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 73. CHINA ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 74. CHINA ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 75. INDIA ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 76. INDIA ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 77. INDIA ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 78. INDIA ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 79. INDIA ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 80. JAPAN ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 81. JAPAN ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 82. JAPAN ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 83. JAPAN ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 84. JAPAN ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 85. ROAPAC ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 86. ROAPAC ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 87. ROAPAC ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 88. ROAPAC ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 89. ROAPAC ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 90. BRAZIL ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 91. BRAZIL ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 92. BRAZIL ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 93. BRAZIL ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 94. BRAZIL ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 95. MEXICO ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 96. MEXICO ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 97. MEXICO ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 98. MEXICO ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 99. MEXICO ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 100. ROLA ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 101. ROLA ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 102. ROLA ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 103. ROLA ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 104. ROLA ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 105. ROW ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 106. ROW ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 107. ROW ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 108. ROW ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 109. ROW ANTIFUNGAL DRUG MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

List of Figures

  • FIG 1. GLOBAL ANTIFUNGAL DRUG MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL ANTIFUNGAL DRUG MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL ANTIFUNGAL DRUG MARKET, KEY TRENDS 2016
  • FIG 5. GLOBAL ANTIFUNGAL DRUG MARKET, GROWTH PROSPECTS 2017-2025
  • FIG 6. GLOBAL ANTIFUNGAL DRUG MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL ANTIFUNGAL DRUG MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL ANTIFUNGAL DRUG MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 10. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 11. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 12. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 13. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 14. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 15. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 16. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 17. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 18. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 19. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 20. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 21. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 22. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 23. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 24. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 25. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 26. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 27. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 28. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 29. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 30. GLOBAL ANTIFUNGAL DRUG MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 31. GLOBAL ANTIFUNGAL DRUG MARKET, REGIONAL SNAPSHOT 2015 & 2025
  • FIG 32. NORTH AMERICA ANTIFUNGAL DRUG MARKET 2015 & 2025 (USD BILLON)
  • FIG 33. EUROPE ANTIFUNGAL DRUG MARKET 2015 & 2025 (USD BILLON)
  • FIG 34. ASIA PACIFIC ANTIFUNGAL DRUG MARKET 2015 & 2025 (USD BILLON)
  • FIG 35. LATIN AMERICA ANTIFUNGAL DRUG MARKET 2015 & 2025 (USD BILLON)
  • FIG 36. GLOBAL ANTIFUNGAL DRUG MARKET, COMPANY MARKET SHARE ANALYSIS (2016)
Back to Top